Concepedia

Irvith M. Carvajal

IM

Statistics

Publications

15

Citations

720

H-Index

14

Active since

2000

Affiliations

Bristol-Myers Squibb (United States)(Current)

Brigham and Women's Hospital

Harvard University

Bristol-Myers Squibb (Germany)

Irvith M. Carvajal is an author at Bristol-Myers Squibb (United States) specializing in life sciences, inflammation, and pharmacology.

Publications per year

2000–2024

15

Publications

15

Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death

Kuniaki Ejima, Matthew D. Layne, Irvith M. Carvajal et al. · The FASEB Journal · 2003 · 118 citations

, , +17

Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice

Philippe Wiesel, Anand Patel, Irvith M. Carvajal et al. · Circulation Research · 2001 · 99 citations · Full text

, , +14

Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2

Roni Mamluk, Irvith M. Carvajal, Brent Morse et al. · mAbs · 2010 · 80 citations · Full text

, , +15

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

Stuart L. Emanuel, Linda J. Engle, Rongrong Zhu et al. · mAbs · 2011 · 73 citations · Full text

, , +17

Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice

Matthew D. Layne, Anand Patel, Yen‐Hsu Chen et al. · The FASEB Journal · 2001 · 68 citations

, , +17

1–5 of 15